Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'TERNARY COMPLEX MODEL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 127 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Chidiac, P
      Considerations in the evaluation of inverse agonism and protean agonism atG protein-coupled receptors

      G PROTEIN PATHWAYS, PT A, RECEPTORS
    2. Lazareno, S
      Quantification of receptor interactions using binding methods (Reprinted from Receptor-Based Drug Design, vol 89, pg 49-77, 1998)

      JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH
    3. Wurch, T; Pauwels, PJ
      Analytical pharmacology of G protein-coupled receptors by stoichiometric expression of the receptor and G alpha protein subunits

      JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
    4. Gjedde, A; Wong, DF
      Quantification of neuroreceptors in living human brain. V. Endogenous neurotransmitter inhibition of haloperidol binding in psychosis

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    5. Azzi, M; Pineyro, G; Pontier, SP; Parent, S; Ansanay, H; Bouvier, M
      Allosteric effects of G protein overexpression on the binding of beta-adrenergic ligands with distinct inverse efficacies

      MOLECULAR PHARMACOLOGY
    6. Pineyro, G; Azzi, M; De Lean, A; Schiller, P; Bouvier, M
      Short-term inverse-agonist treatment induces reciprocal changes in delta-opioid agonist and inverse-agonist binding capacity

      MOLECULAR PHARMACOLOGY
    7. Wade, SM; Lan, KL; Moore, DJ; Neubig, RR
      Inverse agonist activity at the alpha(2A)-adrenergic receptor

      MOLECULAR PHARMACOLOGY
    8. Seifert, R; Wenzel-Seifert, K; Gether, U; Kobilka, BK
      Functional differences between full and partial agonists: Evidence for ligand-specific receptor conformations

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    9. Martinelli, R; Sabroe, I; LaRosa, G; Williams, TJ; Pease, JE
      The CC chemokine eotaxin (CCL11) is a partial agonist of CC chemokine receptor 2b

      JOURNAL OF BIOLOGICAL CHEMISTRY
    10. Cordeaux, Y; Nickolls, SA; Flood, LA; Graber, SG; Strange, PG
      Agonist regulation of D-2 dopamine receptor/G protein interaction - Evidence for agonist selection of G protein subtype

      JOURNAL OF BIOLOGICAL CHEMISTRY
    11. Park, P; Sum, CS; Hampson, DR; Van Tol, HHM; Wells, JW
      Nature of the oligomers formed by muscarinic m2 acetylcholine receptors inSf9 cells

      EUROPEAN JOURNAL OF PHARMACOLOGY
    12. Martin, MW; Scott, AW; Johnston, DE; Griffin, S; Luedtke, RR
      Typical antipsychotics exhibit inverse agonist activity at rat dopamine D1-like receptors expressed in Sf9 cells

      EUROPEAN JOURNAL OF PHARMACOLOGY
    13. Huang, P; Li, J; Chen, CG; Visiers, I; Weinstein, H; Liu-Chen, LY
      Functional role of a conserved motif in TM6 of the rat mu opioid receptor:Constitutively active and inactive receptors result from substitutions of Thr6.34(279) with Lys and Asp

      BIOCHEMISTRY
    14. Li, J; Huang, P; Chen, CG; de Riel, JK; Weinstein, H; Liu-Chen, LY
      Constitutive activation of the mu opioid receptor by mutation of D3.49(164), but not D3.32(147): D3.49(164) is critical for stabilization of the inactive form of the receptor and for its expression

      BIOCHEMISTRY
    15. Pauwels, PJ; Tardif, S; Colpaert, FC
      Differential signalling of both wild-type and Thr(343) Arg dopamine D-2short receptor by partial agonists in a G-protein-dependent manner

      BIOCHEMICAL PHARMACOLOGY
    16. Chen, A; Gao, ZG; Barak, D; Liang, BT; Jacobson, KA
      Constitutive activation of A(3) adenosine receptors by site-directed mutagenesis

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    17. Christopoulos, A; Grant, MKO; El-Fakahany, EE
      Transducer abstraction - A novel approach to the detection of partial agonist efficacy in radioligand binding studies

      JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
    18. Daeffler, L; Landry, Y
      Inverse agonism at heptahelical receptors: concept, experimental approach and therapeutic potential

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    19. Durr, JA; Hensen, J; Ehnis, T; Blankenship, MS
      Chlorpropamide upregulates antidiuretic hormone receptors and unmasks constitutive receptor signaling

      AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
    20. Ambrosio, C; Molinari, P; Cotecchia, S; Costa, T
      Catechol-binding serines of beta(2)-adrenergic receptors control the equilibrium between active and inactive receptor states

      MOLECULAR PHARMACOLOGY
    21. Shea, LD; Neubig, RR; Linderman, JJ
      Timing is everything - The role of kinetics in G protein activation

      LIFE SCIENCES
    22. Pauwels, PJ; Tardif, S; Wurch, T; Colpaert, FC
      Facilitation of constitutive alpha(2A)-adrenoceptor activity by both single amino acid mutation (Thr(373)Lys) and G(alpha o) protein coexpression: Evidence for inverse agonism

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    23. Malmberg, A; Strange, PG
      Site-directed mutations in the third intracellular loop of the serotonin 5-HT1A receptor alter G protein coupling from G(i) to G(s) in a ligand-dependent manner

      JOURNAL OF NEUROCHEMISTRY
    24. de Vries, B; Meurs, H; Roffel, AF; Elzinga, CRS; Hoiting, BH; de Vries, MML; Zaagsma, J
      beta-agonist-induced constitutive beta(2)-adrenergic receptor activity in bovine tracheal smooth muscle

      BRITISH JOURNAL OF PHARMACOLOGY
    25. Maack, C; Cremers, B; Flesch, M; Hoper, A; Sudkamp, M; Bohm, M
      Different intrinsic activities of bucindolol, carvedilol and metoprolol inhuman failing myocardium

      BRITISH JOURNAL OF PHARMACOLOGY
    26. de Ligt, RAF; Kourounakis, AP; Ijzerman, AP
      Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery

      BRITISH JOURNAL OF PHARMACOLOGY
    27. Pauwels, PJ
      Diverse signalling by 5-hydroxytryptamine (5-HT) receptors

      BIOCHEMICAL PHARMACOLOGY
    28. Gilbert, TL; Prossnitz, ER; Sklar, LA
      The uncoupled state of the human formyl peptide receptor

      JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH
    29. Hoare, SRJ; Usdin, TB
      Quantitative cell membrane-based radioligand binding assays for parathyroid hormone receptors

      JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
    30. Post, SR; Hammond, HK; Insel, PA
      beta-adrenergic receptors and receptor signaling in heart failure

      ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
    31. Cavalli, A; Babey, AM; Loh, HH
      Altered adenylyl cyclase responsiveness subsequent to point mutations of Asp 128 in the third transmembrane domain of the delta-opioid receptor

      NEUROSCIENCE
    32. Strange, PE
      Agonism and inverse agonism at dopamine D-2-like receptors

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    33. Pauwels, PJ; Gouble, A; Wurch, T
      Activation of constitutive 5-hydroxytryptamine(1B) receptor by a series ofmutations in the BBXXB motif: positioning of the third intracellular loop distal junction and its G(0)alpha protein interactions

      BIOCHEMICAL JOURNAL
    34. Gurguis, GNM; Vo, SP; Blakeley, J; Orsulak, PJ; Rush, AJ
      Characteristics of norepinephrine and clonidine displacement of [H-3]yohimbine binding to platelet alpha(2)-adrenoreceptors in healthy volunteers

      PSYCHIATRY RESEARCH
    35. Siehler, S; Hoyer, D
      Characterisation of human recombinant somatostatin receptors. 2. Modulation of GTP gamma S binding

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    36. Siehler, S; Hoyer, D
      Characterisation of human recombinant somatostatin receptors. 4. Modulation of phospholipase C activity

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    37. Grotewiel, MS; Sanders-Bush, E
      Differences in agonist-independent activity of 5-HT2A and 5-HT2C receptorsrevealed by heterologous expression

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    38. Riccobene, TA; Omann, GM; Linderman, JJ
      Modeling activation and desensitization of G-protein coupled receptors - Provides insight into ligand efficacy

      JOURNAL OF THEORETICAL BIOLOGY
    39. Hoare, SRJ; De Vries, G; Usdin, TB
      Measurement of agonist and antagonist ligand-binding parameters at the human parathyroid hormone type 1 receptor: Evaluation of receptor states and modulation by guanine nucleotide

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    40. Befort, K; Zilliox, C; Filliol, D; Yue, SY; Kieffer, BL
      Constitutive activation of the delta opioid receptor by mutations in transmembrane domains III and VII

      JOURNAL OF BIOLOGICAL CHEMISTRY
    41. Mason, DA; Moore, JD; Green, SA; Liggett, SB
      A gain-of-function polymorphism in a G-protein coupling domain of the human beta(1)-adrenergic receptor

      JOURNAL OF BIOLOGICAL CHEMISTRY
    42. Vichi, P; Whelchel, A; Posada, J
      Transmembrane helix 7 of the endothelin B receptor regulates downstream signaling

      JOURNAL OF BIOLOGICAL CHEMISTRY
    43. Lu, ZL; Hulme, EC
      The functional topography of transmembrane domain 3 of the M-1 muscarinic acetylcholine receptor, revealed by scanning mutagenesis

      JOURNAL OF BIOLOGICAL CHEMISTRY
    44. Seifert, R; Wenzel-Seifert, K; Gether, U; Lam, VT; Kobilka, BK
      Examining the efficiency of receptor/G-protein coupling with a cleavable beta(2)-adrenoceptor-G(s alpha) fusion protein

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    45. Strange, PG
      G-protein coupled receptors - Conformations and states

      BIOCHEMICAL PHARMACOLOGY
    46. Christopoulos, A; El-Fakahany, EE
      Qualitative and quantitative assessment of relative agonist efficacy

      BIOCHEMICAL PHARMACOLOGY
    47. Giraldo, J
      A pH-dependent model of the activation mechanism of the histamine H-2 receptor

      BIOCHEMICAL PHARMACOLOGY
    48. Onaran, HO; Gurdal, H
      Ligand efficacy and affinity in an interacting 7TM receptor model

      TRENDS IN PHARMACOLOGICAL SCIENCES
    49. Kenakin, T
      Efficacy in drug receptor theory: outdated concept or under-valued tool?

      TRENDS IN PHARMACOLOGICAL SCIENCES
    50. Granas, C; Nordvall, G; Larhammar, D
      Mutagenesis of the human 5-HT1B receptor: Differences from the closely related 5-HT1A receptor and the role of residue F331 in signal transduction

      JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH
    51. HOUSTON DB; HOWLETT AC
      DIFFERENTIAL RECEPTOR-G-PROTEIN COUPLING EVOKED BY DISSIMILAR CANNABINOID RECEPTOR AGONISTS

      Cellular signalling
    52. Pauwels, PJ; Wurch, T
      Amino acid domains involved in constitutive activation of G-protein-coupled receptors - Review

      MOLECULAR NEUROBIOLOGY
    53. LU DS; VAGE DI; CONE RD
      A LIGAND-MIMETIC MODEL FOR CONSTITUTIVE ACTIVATION OF THE MELANOCORTIN-1 RECEPTOR

      Molecular endocrinology
    54. HARIKUMAR KG; CHATTOPADHYAY A
      METAL-ION AND GUANINE-NUCLEOTIDE MODULATIONS OF AGONIST INTERACTION IN G-PROTEIN-COUPLED SEROTONIN(1A) RECEPTORS FROM BOVINE HIPPOCAMPUS

      Cellular and molecular neurobiology
    55. RUBENSTEIN LA; LANZARA RG
      ACTIVATION OF G-PROTEIN-COUPLED RECEPTORS ENTAILS CYSTEINE MODULATIONOF AGONIST BINDING

      Journal of molecular structure. Theochem
    56. WIENS BL; NELSON CS; NEVE KA
      CONTRIBUTION OF SERINE RESIDUES TO CONSTITUTIVE AND AGONIST-INDUCED SIGNALING VIA THE D-2S DOPAMINE-RECEPTOR - EVIDENCE FOR MULTIPLE, AGONIST-SPECIFIC ACTIVE CONFORMATIONS

      Molecular pharmacology
    57. GANGULI SC; PARK CG; HOLTMANN MH; HADAC EM; KENAKIN TP; MILLER LJ
      PROTEAN EFFECTS OF A NATURAL PEPTIDE AGONIST OF THE G-PROTEIN-COUPLEDSECRETIN RECEPTOR DEMONSTRATED BY RECEPTOR MUTAGENESIS

      The Journal of pharmacology and experimental therapeutics
    58. MALMBERG A; MIKAELS A; MOHELL N
      AGONIST AND INVERSE AGONIST ACTIVITY AT THE DOPAMINE D-3 RECEPTOR MEASURED BY GUANOSINE 5'-[GAMMA-THIO]TRIPHOSPHATE-[S-35] BINDING

      The Journal of pharmacology and experimental therapeutics
    59. ZUSCIK MJ; PORTER JE; GAIVIN R; PEREZ DM
      IDENTIFICATION OF A CONSERVED SWITCH RESIDUE RESPONSIBLE FOR SELECTIVE CONSTITUTIVE ACTIVATION OF THE BETA(2)-ADRENERGIC RECEPTOR

      The Journal of biological chemistry
    60. GETHER U; KOBILKA BK
      G-PROTEIN-COUPLED RECEPTORS - II - MECHANISM OF AGONIST ACTIVATION

      The Journal of biological chemistry
    61. GRISHINA G; BERLOT CH
      MUTATIONS AT THE DOMAIN INTERFACE OF G(S-ALPHA) IMPAIR RECEPTOR-MEDIATED ACTIVATION BY ALTERING RECEPTOR AND GUANINE-NUCLEOTIDE-BINDING

      The Journal of biological chemistry
    62. MALMBERG A; MOHELL N; HOOK BB; JOHANSSON AM; HACKSELL U; NORDVALL G
      INTERACTIONS OF LIGANDS WITH ACTIVE AND INACTIVE CONFORMATIONS OF THEDOPAMINE D-2 RECEPTOR

      European journal of pharmacology
    63. SEIFERT R; LEE TW; LAM VT; KOBILKA BK
      RECONSTITUTION OF BETA(2)-ADRENOCEPTOR-GTP-BINDING-PROTEIN INTERACTION IN SF9 CELLS - HIGH COUPLING EFFICIENCY IN A BETA(2)-ADRENOCEPTOR-G(S-ALPHA) FUSION PROTEIN

      European journal of biochemistry
    64. COLQUHOUN D
      BINDING, GATING, AFFINITY AND EFFICACY - THE INTERPRETATION OF STRUCTURE-ACTIVITY-RELATIONSHIPS FOR AGONISTS AND OF THE EFFECTS OF MUTATINGRECEPTORS

      British Journal of Pharmacology
    65. GARDNER B; STRANGE PG
      AGONIST ACTION AT D-2(LONG) DOPAMINE-RECEPTORS - LIGAND-BINDING AND FUNCTIONAL ASSAYS

      British Journal of Pharmacology
    66. CHIDIAC P
      RETHINKING RECEPTOR-G PROTEIN-EFFECTOR INTERACTIONS

      Biochemical pharmacology
    67. SUGIURA M; YAMAMOTO K; SAWADA Y; IGA T
      PHARMACOKINETIC PHARMACODYNAMIC ANALYSIS OF NEUTROPHIL PROLIFERATION INDUCED BY RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR (RHG-CSF)- COMPARISON BETWEEN INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION/

      Biological & pharmaceutical bulletin
    68. MUKESH D; JADHAV S; BANERJI AA; THAKKAR K; BEVINAKATTI HS
      LIPASE-CATALYZED ESTERIFICATION REACTIONS - EXPERIMENTAL AND MODELINGSTUDIES

      Journal of chemical technology and biotechnology
    69. UGUR O; ONARAN HO
      ALLOSTERIC EQUILIBRIUM-MODEL EXPLAINS STEADY-STATE COUPLING OF BETA-ADRENERGIC RECEPTORS TO ADENYLATE-CYCLASE IN TURKEY ERYTHROCYTE-MEMBRANES

      Biochemical journal
    70. WOOKEY PJ; CAO Z; VANGEENEN RCI; VOSKUIL M; DARBY IA; KOMERS R; COOPER ME
      INCREASED DENSITY OF RENAL AMYLIN BINDING-SITES IN EXPERIMENTAL-HYPERTENSION

      Hypertension
    71. SEN M; SHAH A; MARSH L
      2 TYPES OF ALPHA-FACTOR RECEPTOR DETERMINANTS FOR PHEROMONE SPECIFICITY IN THE MATING-INCOMPATIBLE YEASTS SACCHAROMYCES-CEREVISIAE AND S-KLUYVERI

      Current genetics
    72. SAWADA Y; YAMADA Y; IGA T
      QUANTITATIVE-EVALUATION OF PHARMACOLOGICAL EFFECTS AND ADVERSE-EFFECTS BASED ON RECEPTOR OCCUPANCY THEORY

      Yakugaku zasshi
    73. VOGEL WK; SHEEHAN DM; SCHIMERLIK MI
      SITE-DIRECTED MUTAGENESIS ON THE M2 MUSCARINIC ACETYLCHOLINE-RECEPTOR- THE SIGNIFICANCE OF TYR403 IN THE BINDING OF AGONISTS AND FUNCTIONAL COUPLING

      Molecular pharmacology
    74. CHEN WJ; ARMOUR S; WAY J; CHEN G; WATSON C; IRVING P; COBB J; KADWELL S; BEAUMONT K; RIMELE T; KENAKIN T
      EXPRESSION CLONING AND RECEPTOR PHARMACOLOGY OF HUMAN CALCITONIN RECEPTORS FROM MCF-7 CELLS AND THEIR RELATIONSHIP TO AMYLIN RECEPTORS

      Molecular pharmacology
    75. GURDAL H; BOND RA; JOHNSON MD; FRIEDMAN E; ONARAN HO
      AN EFFICACY-DEPENDENT EFFECT OF CARDIAC OVEREXPRESSION OF BETA(2)-ADRENOCEPTOR ON LIGAND AFFINITY IN TRANSGENIC MICE

      Molecular pharmacology
    76. KHAWAJA X; ENNIS C; MINCHIN MCW
      PHARMACOLOGICAL CHARACTERIZATION OF RECOMBINANT HUMAN 5-HYDROXYTRYPTAMINE(1A) RECEPTORS USING A NOVEL ANTAGONIST RADIOLIGAND, [H-3] WAY-100635

      Life sciences
    77. WAELBROECK M; BOUFRAHI L; SWILLENS S
      7 HELIX RECEPTORS ARE ENZYMES CATALYZING G-PROTEIN ACTIVATION - WHAT IS THE AGONIST K-ACT

      Journal of theoretical biology
    78. GARDNER BR; HALL DA; STRANGE PG
      AGONIST ACTION AT D-2(SHORT) DOPAMINE-RECEPTORS DETERMINED IN LIGAND-BINDING AND FUNCTIONAL ASSAYS

      Journal of neurochemistry
    79. BARR AJ; MANNING DR
      AGONIST-INDEPENDENT ACTIVATION OF G(Z) BY THE 5-HYDROXYTRYPTAMINE(1A)RECEPTOR COEXPRESSED IN SPODOPTERA-FRUGIPERDA CELLS - DISTINGUISHING INVERSE AGONISTS FROM NEUTRAL ANTAGONISTS

      The Journal of biological chemistry
    80. PARDO L; CAMPILLO M; GIRALDO J
      THE EFFECT OF THE MOLECULAR MECHANISM OF G-PROTEIN-COUPLED RECEPTOR ACTIVATION ON THE PROCESS OF SIGNAL-TRANSDUCTION

      European journal of pharmacology
    81. VANDERHEYDEN PML; VANLIEFDE I; DEBACKER JP; VAUQUELIN G
      NONCOMPETITIVE BINDING OF THE NONPEPTIDE ANTAGONIST BIBP3226 TO RAT FOREBRAIN NEUROPEPTIDE Y-1 RECEPTORS

      European journal of pharmacology
    82. SPALDING TA; BURSTEIN ES; WELLS JW; BRANN MR
      CONSTITUTIVE ACTIVATION OF THE M5-MUSCARINIC RECEPTOR BY A SERIES OF MUTATIONS AT THE EXTRACELLULAR END OF TRANSMEMBRANE-6

      Biochemistry
    83. CHIDIAC P; GREEN MA; PAWAGI AB; WELLS JW
      CARDIAC MUSCARINIC RECEPTORS - COOPERATIVITY AS THE BASIS FOR MULTIPLE STATES OF AFFINITY

      Biochemistry
    84. GREEN MA; CHIDIAC P; WELLS JW
      CARDIAC MUSCARINIC RECEPTORS - RELATIONSHIP BETWEEN THE G-PROTEIN ANDMULTIPLE STATES OF AFFINITY

      Biochemistry
    85. KRUMINS AM; BARBER R
      EXAMINATION OF THE EFFECTS OF INCREASING G(S) PROTEIN ON BETA(2)-ADRENERGIC RECEPTOR, G(S), AND ADENYLYL-CYCLASE INTERACTIONS

      Biochemical pharmacology
    86. GARCIASAINZ JA; CRUZMUNOZ ME; ROMEROAVILA MT
      CHARACTERIZATION OF THE BETA(2) ADRENOCEPTORS OF DOG LIVER

      Comparative biochemistry and physiology. Part C, Pharmacology toxicology & endocrinology
    87. PAK MD; FISHMAN PH
      ANOMALOUS BEHAVIOR OF CGP 12177A ON BETA(1)-ADRENERGIC RECEPTORS

      Journal of receptor and signal transduction research
    88. DOMALEWSKI MD; GUYER DA; FREER RJ; MUTHUKUMARASWAMY N; SKLAR LA
      FIXATION TRAPS FORMYL PEPTIDE RECEPTORS IN HIGH AND LOW-AFFINITY FORMS THAT CAN BE REGULATED BY GTP[S] IN THE ABSENCE OF LIGAND

      Journal of receptor and signal transduction research
    89. GRIFFON N; PILON C; SAUTEL F; SCHWARTZ JC; SOKOLOFF P
      ANTIPSYCHOTICS WITH INVERSE AGONIST ACTIVITY AT THE DOPAMINE D-3 RECEPTOR

      Journal of neural transmission
    90. OBOYLE KM; LAWLER M
      D-2 RECEPTOR AGONISTS AND PARTIAL AGONISTS - RELATIONSHIP BETWEEN RECEPTOR-BINDING MEASURES AND FUNCTIONAL-ACTIVITY

      Biochemical Society transactions
    91. SMIT MJ; LEURS R; ALEWIJNSE AE; BLAUW J; AMERONGEN GPV; VANDEVREDE Y; ROOVERS E; TIMMERMAN H
      INVERSE AGONISM OF HISTAMINE H-2 ANTAGONISTS ACCOUNTS FOR UP-REGULATION OF SPONTANEOUSLY ACTIVE HISTAMINE H-2 RECEPTORS

      Proceedings of the National Academy of Sciences of the United Statesof America
    92. CLARK RB; ALLAL C; FRIEDMAN J; JOHNSON M; BARBER R
      STABLE ACTIVATION AND DESENSITIZATION OF BETA(2)-ADRENERGIC RECEPTOR STIMULATION OF ADENYLYL-CYCLASE BY SALMETEROL - EVIDENCE FOR QUASI-IRREVERSIBLE BINDING TO AN EXOSITE

      Molecular pharmacology
    93. WOODWARD R; COLEY C; DANIELL S; NAYLOR LH; STRANGE PG
      INVESTIGATION OF THE ROLE OF CONSERVED SERINE RESIDUES IN THE LONG FORM OF THE RAT D-2 DOPAMINE-RECEPTOR USING SITE-DIRECTED MUTAGENESIS

      Journal of neurochemistry
    94. MALMBERG A; HOOK BB; JOHANSSON AM; HACKSELL U
      NOVEL (R)-2-AMINO-5-FLUOROTETRALINS - DOPAMINERGIC ANTAGONISTS AND INVERSE AGONISTS

      Journal of medicinal chemistry
    95. AQUILLA E; WHELCHEL A; KNOT HJ; NELSON M; POSADA J
      ACTIVATION OF MULTIPLE MITOGEN-ACTIVATED PROTEIN-KINASE SIGNAL-TRANSDUCTION PATHWAYS BY THE ENDOTHELIN-B RECEPTOR REQUIRES THE CYTOPLASMIC TAIL

      The Journal of biological chemistry
    96. GARDELLA TJ; LUCK MD; FAN MH; LEE CW
      TRANSMEMBRANE RESIDUES OF THE PARATHYROID-HORMONE (PTH) PTH-RELATED PEPTIDE RECEPTOR THAT SPECIFICALLY AFFECT BINDING AND SIGNALING BY AGONIST LIGANDS/

      The Journal of biological chemistry
    97. PARENT JL; LEGOUILL C; DEBRUMFERNANDES AJ; ROLAPLESZCZYNSKI M; STANKOVA J
      MUTATIONS OF 2 ADJACENT AMINO-ACIDS GENERATE INACTIVE AND CONSTITUTIVELY ACTIVE FORMS OF THE HUMAN PLATELET-ACTIVATING-FACTOR RECEPTOR

      The Journal of biological chemistry
    98. LIU J; BLIN N; CONKLIN BR; WESS J
      MOLECULAR MECHANISMS INVOLVED IN MUSCARINIC ACETYLCHOLINE RECEPTOR-MEDIATED G-PROTEIN ACTIVATION STUDIED BY INSERTION MUTAGENESIS

      The Journal of biological chemistry
    99. GARCIASAINZ JA; ROMEROAVILA MT; GONZALEZESPINOSA C
      COEXPRESSION OF ALPHA(1A)-ADRENOCEPTORS AND ALPHA(1B)-ADRENOCEPTORS IN THE LIVER OF THE RHESUS-MONKEY (MACACA-MULATTA)

      European journal of pharmacology
    100. GARDELLA TJ; LUCK MD; JENSEN GS; SCHIPANI E; POTTS JT; JUPPNER H
      INVERSE AGONISM OF AMINO-TERMINALLY TRUNCATED PARATHYROID-HORMONE (PTH) AND PTH-RELATED PEPTIDE (PTHRP) ANALOGS REVEALED WITH CONSTITUTIVELY ACTIVE MUTANT PTH PTHRP RECEPTORS/

      Endocrinology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 14:09:32